Kaempferol-3-O-galactoside

CAS No. 23627-87-4

Kaempferol-3-O-galactoside( Kaempferol 3-O-beta-D-galactoside )

Catalog No. M24073 CAS No. 23627-87-4

Kaempferol-3-O-galactoside has antioxidant, anti-inflammatory and antinociceptive activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 In Stock
10MG 500 In Stock
25MG 791 In Stock
50MG 1062 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kaempferol-3-O-galactoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Kaempferol-3-O-galactoside has antioxidant, anti-inflammatory and antinociceptive activities.
  • Description
    Kaempferol-3-O-galactoside has antioxidant, anti-inflammatory and antinociceptive activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Kaempferol 3-O-beta-D-galactoside
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Immunology & Inflammation related
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23627-87-4
  • Formula Weight
    448.38
  • Molecular Formula
    C21H20O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC[C@H]([C@@H]([C@@H]([C@H]1O)O)O)O[C@H]1OC1=C(c(cc2)ccc2O)Oc(cc(cc2O)O)c2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.da Silva I, et al. Structure determination of monohydrated trifolin (kaempferol 3-O-β-D-galactopyranoside) from laboratory powder diffraction data. J Pharm Sci. 2011;100(4):1588-1593.
molnova catalog
related products
  • UUN44923

    UUN44923 is a FTO inhibitor.?It may be useful for treating diseases assocd.?with FTO targets, obesity, metabolic syndrome (MS) , type 2 diabetes (T2D) , Alzheimer's diseases, breast cancers, small- cell lung cancers, a human bone marrow striated muscle cancer, a pancreatic cancer, malignant glioblastoma and the like.?

  • 6,7-Dihydro-2H-cyclo...

    6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one is an intermediate used to synthesize Pyridazine derivatives.

  • ML265

    ML265 is a potent PKM2 activator (AC50 : 92 nM) showing little or no effect on PKM1 PKL and PKRinduces tetramerization and reduces tumor formation and size in a mouse xenograft model.?.